Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact

EM Trecarichi, M Tumbarello - Current opinion in infectious …, 2014 - journals.lww.com
Antimicrobial-resistant Gram-negative bacteria in febrile ne... : Current Opinion in Infectious
Diseases Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with …

There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy

EJ Bow - Journal of Antimicrobial Chemotherapy, 2013 - academic.oup.com
The success of modern anticancer treatment is a composite function of enhanced efficacy of
surgical, radiation and systemic treatment strategies and of our collective clinical abilities in …

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

SH Zinner - Clinical infectious diseases, 1999 - academic.oup.com
Over the past 3 decades, considerable changes have occurred in the types of bacteria
causing infection in febrile patients with neutropenia and cancer. Twenty years ago, gram …

Management of febrile neutropenia in the era of bacterial resistance

S Alp, M Akova - Therapeutic advances in infectious disease, 2013 - journals.sagepub.com
Managing cancer patients with fever and neutropenia must be considered as a medical
emergency since any delay in initiating appropriate empirical antibacterial therapy may …

Bacterial infections in low‐risk, febrile neutropenic patients: Over a decade of experience at a comprehensive cancer center

M Kamana, C Escalante, CA Mullen… - … Journal of the …, 2005 - Wiley Online Library
BACKGROUND Accurate identification of low‐risk, febrile neutropenic patients has become
possible only recently. Many such patients are treated with oral antibiotics without …

Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia

KVI Rolston - Clinical infectious diseases, 2005 - academic.oup.com
Infection is the most common complication of chemotherapy-induced neutropenia. Bacterial
infections predominate during the early stages of a neutropenic episode, whereas invasive …

A European Organization for Research and Treatment of Cancer–International Antimicrobial Therapy Group study of secondary infections in febrile, neutropenic …

M Akova, M Paesmans, T Calandra… - Clinical infectious …, 2005 - academic.oup.com
Background. Neutropenic patients with cancer may develop several episodes of fever and
infection during chemotherapy-induced myeloaplasia. Methods. To identify risk factors for …

[HTML][HTML] Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients

ES Horasan, G Ersoz, A Tombak, N Tiftik… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

[PDF][PDF] Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy

JW Hathorn, M Rubin, PA Pizzo - Antimicrobial agents and …, 1987 - Am Soc Microbiol
The efficacy of empirical broad-spectrum antibiotics for the febrile, neutropenic patient is well
established. Traditional wisdom has been that combinations of two or three antibiotics are …

Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients

CO Nijhuis, WA Kamps, SMG Daenen… - Journal of clinical …, 2005 - ascopubs.org
Purpose To investigate the feasibility of withholding antibiotics and early discharge for
patients with chemotherapy-induced neutropenia and fever at low risk of bacterial infection …